Bay Capital Advisors LLC Purchases Shares of 1,089 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bay Capital Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,089 shares of the medical equipment provider's stock, valued at approximately $568,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the fourth quarter valued at about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $18.56 during mid-day trading on Friday, hitting $489.35. 1,145,477 shares of the company were exchanged, compared to its average volume of 2,039,017. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a 50 day moving average of $558.29 and a 200-day moving average of $532.25. The stock has a market cap of $174.29 billion, a price-to-earnings ratio of 76.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Remove Ads

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company's stock.

Analyst Ratings Changes

Several brokerages have weighed in on ISRG. Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target for the company. Robert W. Baird dropped their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 18th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.